Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Y Fuchs

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Molecular Cancer Research : MCR|November 15, 2022
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer CellsNoreen McBrearty, Christina Cho, Jinyun Chen, et al.
Cell Metabolism|February 21, 2023
PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapyDuo Zhang, Albert M Li, Guanghui Hu, et al.
The Journal of Clinical Investigation|May 17, 2021
Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapiesZhen Lu, Angelica Ortiz, Ioannis I Verginadis, et al.
Journal of Virology|July 14, 2021
SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT PathwayDa-Yuan Chen, Nazimuddin Khan, Brianna J Close, et al.
The Journal of Clinical Investigation|November 13, 2012
ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growthLori S Hart, John T Cunningham, Tatini Datta, et al.
Nature Cancer|June 14, 2021
Activation of p38α stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungsJun Gui, Farima Zahedi, Angelica Ortiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
A Potent <i>In Vivo</i> Antitumor Efficacy of Novel Recombinant Type I InterferonKang-Jian Zhang, Xiao-Fei Yin, Yuan-Qin Yang, et al.
Nature Communications|November 4, 2022
Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translationBartosz Mucha, Shuo Qie, Sagar Bajpai, et al.
Science Advances|September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancersYunguang Sun, Ning Yang, Fransiscus E Utama, et al.
JCO Precision Oncology|January 18, 2023
High PD-L2 Predicts Early Recurrence of ER-Positive Breast CancerInna Chervoneva, Amy R Peck, Yunguang Sun, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Molecular Cancer Research : MCR|November 15, 2022
Tumor-Suppressive and Immune-Stimulating Roles of Cholesterol 25-hydroxylase in Pancreatic Cancer CellsNoreen McBrearty, Christina Cho, Jinyun Chen, et al.
Cell Metabolism|February 21, 2023
PHGDH-mediated endothelial metabolism drives glioblastoma resistance to chimeric antigen receptor T cell immunotherapyDuo Zhang, Albert M Li, Guanghui Hu, et al.
The Journal of Clinical Investigation|May 17, 2021
Regulation of intercellular biomolecule transfer-driven tumor angiogenesis and responses to anticancer therapiesZhen Lu, Angelica Ortiz, Ioannis I Verginadis, et al.
Journal of Virology|July 14, 2021
SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT PathwayDa-Yuan Chen, Nazimuddin Khan, Brianna J Close, et al.
The Journal of Clinical Investigation|November 13, 2012
ER stress-mediated autophagy promotes Myc-dependent transformation and tumor growthLori S Hart, John T Cunningham, Tatini Datta, et al.
Nature Cancer|June 14, 2021
Activation of p38α stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungsJun Gui, Farima Zahedi, Angelica Ortiz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2016
A Potent <i>In Vivo</i> Antitumor Efficacy of Novel Recombinant Type I InterferonKang-Jian Zhang, Xiao-Fei Yin, Yuan-Qin Yang, et al.
Nature Communications|November 4, 2022
Tumor suppressor mediated ubiquitylation of hnRNPK is a barrier to oncogenic translationBartosz Mucha, Shuo Qie, Sagar Bajpai, et al.
Science Advances|September 15, 2021
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancersYunguang Sun, Ning Yang, Fransiscus E Utama, et al.
JCO Precision Oncology|January 18, 2023
High PD-L2 Predicts Early Recurrence of ER-Positive Breast CancerInna Chervoneva, Amy R Peck, Yunguang Sun, et al.
Pageof 12